Microarray data—the US FDA, industry and academia
- 1 July 2003
- journal article
- Published by Springer Nature in Nature Biotechnology
- Vol. 21 (7) , 742-743
- https://doi.org/10.1038/nbt0703-742
Abstract
No abstract availableKeywords
This publication has 2 references indexed in Scilit:
- Pharmacogenetics and Pharmacogenomics in Drug Development and Regulatory Decision Making: Report of the First FDA‐PWG‐PhRMA‐DruSafe WorkshopThe Journal of Clinical Pharmacology, 2003
- Medical applications of microarray technologies: a regulatory science perspectiveNature Genetics, 2002